Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 1771 for

Edit search filters
  1. A Study To Evaluate The Surgical Removal Of Residual Brain Tumors Prior To Recurrence

    Rochester, MN

  2. Ommaya Placement For Biomarker Collection

    Rochester, MN

  3. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle

    Jacksonville, FL

  5. A Study Of Entrectinib (RXDX-101) For The Treatment Of Patients With Solid Tumors That Have NTRK1/2/3, ROS1, Or ALK Gene Rearrangements

    Scottsdale/Phoenix, AZ

  6. A Safety And Efficacy Study Of Treatment Combinations With And Without Chemotherapy In Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

    Rochester, MN

  8. The BEACON Study (Breast Cancer Outcomes With NKTR-102)

    Jacksonville, FL, Rochester, MN

  9. Alisertib With Or Without Fulvestrant In Treating Patients With Locally Advanced Or Metastatic, Endocrine-Resistant Breast Cancer

    Rochester, MN

  10. Letrozole in Treating Postmenopausal Women with Ductal Carcinoma in Situ

    Rochester, MN

.

Mayo Clinic Footer